ADMA
insider transactionsADMA BIOLOGICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+31.4K
31.4K buy · 0 sell
Net value · 90d
$250.9K
$250.9K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
3
31.4K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$50.6K
6.4K sh · $7.91
Own +1%
-
Buy·P
Director
$100.1K
12.5K sh · $8.01
Own +2%
-
Buy·P
Director
$100.1K
12.5K sh · $8.01
Own +3%
-
Other·F
COO and SVP, Compliance
$185.5K
20.4K sh · $9.11
Own -4%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Jerrold B Grossman | Buy P | 6.4K | $50.6K |
| May 12, 2026 | Jerrold B Grossman | Buy P | 12.5K | $100.1K |
| May 11, 2026 | Jerrold B Grossman | Buy P | 12.5K | $100.1K |
| Apr 1, 2026 | Kaitlin M. Kestenberg-Messina | Other F | 20.4K | $185.5K |
About ADMA insider trading
This page tracks insider transactions for ADMA BIOLOGICS, INC. (ADMA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.